Reliv' International, Inc. (RELV)
$3.71
Rating:
Recommendation:
Neutral
| Symbol | RELV |
|---|---|
| Price | $3.71 |
| Beta | 0.144 |
| Volume Avg. | 0.00M |
| Market Cap | 6.724M |
| Shares () | - |
| 52 Week Range | 1.51-5.5 |
| 1y Target Est | - |
| DCF Unlevered | RELV DCF -> | |
|---|---|---|
| DCF Levered | RELV LDCF -> | |
| ROE | -1.53% | Neutral |
| ROA | -1.05% | Neutral |
| Operating Margin | - | |
| Debt / Equity | 46.11% | Neutral |
| P/E | - | |
| P/B | 0.57 | Buy |
Latest RELV news
About
Download (Excel)Reliv' International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company's basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules. The company markets and sells its products through a direct selling system of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. Reliv' International, Inc. was founded in 1988 and is headquartered in Chesterfield, Missouri.